CA2475066A1 - Rhamnose binding protein - Google Patents

Rhamnose binding protein Download PDF

Info

Publication number
CA2475066A1
CA2475066A1 CA002475066A CA2475066A CA2475066A1 CA 2475066 A1 CA2475066 A1 CA 2475066A1 CA 002475066 A CA002475066 A CA 002475066A CA 2475066 A CA2475066 A CA 2475066A CA 2475066 A1 CA2475066 A1 CA 2475066A1
Authority
CA
Canada
Prior art keywords
rbp
rhamnose
antibody
cell
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002475066A
Other languages
English (en)
French (fr)
Inventor
Richard J. Lipscombe
Stephen John Carter
Michael Ruane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solbec Pharmaceuticals Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2475066A1 publication Critical patent/CA2475066A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002475066A 2002-02-07 2003-02-07 Rhamnose binding protein Abandoned CA2475066A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPS0364A AUPS036402A0 (en) 2002-02-07 2002-02-07 Rhamnose binding protein
AUPS0364 2002-02-07
PCT/AU2003/000135 WO2003066679A1 (en) 2002-02-07 2003-02-07 Rhamnose binding protein

Publications (1)

Publication Number Publication Date
CA2475066A1 true CA2475066A1 (en) 2003-08-14

Family

ID=3833965

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002475066A Abandoned CA2475066A1 (en) 2002-02-07 2003-02-07 Rhamnose binding protein

Country Status (8)

Country Link
EP (1) EP1472287A4 (ja)
JP (1) JP2005538931A (ja)
CN (1) CN1639191A (ja)
AU (1) AUPS036402A0 (ja)
CA (1) CA2475066A1 (ja)
HK (1) HK1080089A1 (ja)
NZ (1) NZ534485A (ja)
WO (1) WO2003066679A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0513881D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
WO2009040726A2 (en) * 2007-09-24 2009-04-02 Universite De Geneve Rhamnose antagonists and use thereof

Also Published As

Publication number Publication date
JP2005538931A (ja) 2005-12-22
EP1472287A1 (en) 2004-11-03
CN1639191A (zh) 2005-07-13
WO2003066679A1 (en) 2003-08-14
NZ534485A (en) 2006-09-29
AUPS036402A0 (en) 2002-02-28
HK1080089A1 (zh) 2006-04-21
EP1472287A4 (en) 2005-10-05

Similar Documents

Publication Publication Date Title
EP1126028B1 (en) Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same
Del Vecchio et al. In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients
Bitar et al. Hsp27 is a mediator of sustained smooth muscle contraction in response to bombesin
US7205108B2 (en) Trp8, Trp9 and Trp10, novel markers for cancer
US4954436A (en) Dihydropyridine-sensitive calcium channel as a tumor associated marker
JP5836940B2 (ja) ソリシジン由来ペプチドならびにｔｒｐｖ−６がんの検出および薬剤送達のための方法
US7348152B2 (en) Rhamnose binding protein
CA2475066A1 (en) Rhamnose binding protein
US20080038248A1 (en) Proteins Ligands For Nkg2d And Ul16 Receptors And Uses Thereof
Schulz et al. Immunohistochemical detection of bombesin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies
AU2003202322B2 (en) Rhamnose binding protein
US6403325B1 (en) Methods and compounds for treating alzheimer's disease
US5741651A (en) Assays for identifiying compounds that bind to the gastrin releasing peptide receptor
JP2004526148A (ja) Ｐ−糖タンパク質及び他の細胞表面リセプター、ポンプ、及びタンパク質のコンホメーションの変化を、定性及びコンホメーションによる定量的な検出の抗体競合試験（ａｃｔ）、及びその使用
JPH07501524A (ja) ｕＰＡ−Ｒの検出・分離方法及びｕＰＡのｕＰＡ−Ｒへの結合阻止方法
US20080187935A1 (en) Homo and Heterodimer Proteins of the Abcg Family, Methods For Detection and Screening Modulators Thereof
ES2378417T3 (es) KCNB: una proteína del canal de potasio
US6245522B1 (en) Master molecular rheostat switch for cell signaling
JP2003528599A (ja) Ｇタンパク質共役レセプター
US6232443B1 (en) Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
JP2005538931A5 (ja)
Shafir et al. The melanocyte-stimulating hormone (MSH) receptor in M2R mouse melanoma tumours: solubilization and properties of the receptor-MSH complex and its covalently crosslinked conjugate
US6803452B2 (en) RPTP-β antibodies
WO2002059608A2 (en) Compositions and methods related to chemokine (c motif) xc receptor 1 (ccxcr1)
US20030086928A1 (en) Compositions associated with complex formation and methods of use thereof

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued